Octave Bioscience
Karen Qiu Zhou has worked in the medical laboratory field since 2006. Karen Qiu began their career as a Medical Laboratory Scientist at Aotea Pathology and was responsible for executing and analyzing tests to aid physicians in diagnosing and treating diseases. In 2012, they moved to Telome Health, Inc. where they were a Clinical Laboratory Scientist and was responsible for the Quality Assurance Program of the laboratory, preparing different State license applications, and performing molecular genetic Telotest. In 2013, they joined Ascend Clinical and Genomics as a Clinical Laboratory Scientist and was responsible for validating new tests, statistical data analysis, SOP writing, and training technical staff. Karen Qiu also relocated and set up the Ascend Genomics PCR Lab and immunohistochemistry Lab to meet CAP and CLIA laboratory standards. In 2014, they worked at Saint Francis Memorial Hospital as a Clinical Laboratory Scientist, performing lab testing in the hematology, blood bank, and urinalysis departments. In 2017, they joined Color Genomics as a Clinical Laboratory Technologist, performing next generation sequencing testing and being responsible for lab quality assurance process. Karen Qiu currently works at Octave Bioscience as a Sr. Clinical Lab Scientist.
Karen Qiu Zhou attended Massey University from 2003 to 2006, where they earned a Bachelor of Medical Laboratory Science in the field of Medical Laboratory Science.
This person is not in any offices
Octave Bioscience
Octave Bioscience’s Comprehensive Care Platform provides a quantitative, objective measurement system designed to expand clinical insights in neurodegenerative disease, beginning with MS. It provides multiple layers of insight to provide a 360 degree view with a longitudinal perspective of disease progression. The first layer measures the patient’s underlying biology with blood based biomarkers that quantitatively and objectively assess inflammation and immune modulation. The second layer includes advanced measurement using improved MRI readings and interpretation to reveal more insights at the CNS layer, including the brain and spine. The final layer features real time tracking of symptoms via monitoring with mobile tools, sensors and wearables to identify changes in disease and alert care teams. All of this data is integrated into protocols, supported by decision support tools and feeds into a dashboard for ease of use. The Octave Platform allows individual and population views to facilitate better stratification and contextual interventions.